Mukka Proteins growth ratios

·FMCG & RetailChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025
+44.0%−27.1%
+20.8%−10.0%
+20.5%−12.7%
+18.7%−35.3%
+12.3%−50.0%
+50.6%+14.4%
+15.8%+11.8%
+0.6%+25.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MUKKA₹24.68

Mukka Proteins Limited

· FMCG & Retail
₹ CrorePeersNARMADAKSEMcap ₹740 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—-27.1+44.0—
EBITDA Growth—-10.0+20.8—
EBIT Growth—-12.7+20.5—
Net Income Growth—-35.3+18.7—
EPS Growth—-50.0+12.3—
Total Assets Growth—+14.4+50.6—
Total Equity Growth—+11.8+15.8—
Cash from Operations Growth—+25.6+0.6—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.